Recurrent Classical Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Recurrent Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| JAK-inhibition in Recurrent Classical Hodgkin Lymphoma (NCT02164500) | University of Cologne | 2015-10-01 |
Track Recurrent Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.